AI assistant
Sending…
Sopharma AD — Director's Dealing 2021
Nov 19, 2021
2543_rns_2021-11-19_7ae987b0-34f8-4723-897a-9ea17b21b183.pdf
Director's Dealing
Open in viewerOpens in your device viewer
NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014
"Sopharma" AD (the "Company") announces that it was notified by "Donev Investments Holding" AD related to Ognian Donev, that "Donev Investments Holding" AD executed the following transactions related to shares in the Company:
| Date and time of the transaction |
Operation | Number of rights |
Unit price (BGN) |
|---|---|---|---|
| 17.11.2021 | Acquired rights for warrants issue |
8 118 751,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
296 997,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
200 042,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
3 502 961,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
1 029 812,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
70 188,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
751 463,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
176 500,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
23 800,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
5 000,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
11 602,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
1 150,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
6 500,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
130 249,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
23 500,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
1 000,00 | 0,01 |
| 17.11.2021 | Acquired rights for warrants issue |
69 236,00 | 0,01 |
| 17.11.2021 | Acquired rights | 20 543,00 | 0,01 |
| for warrants issue | |||
|---|---|---|---|
| 17.11.2021 | Acquired rights | 4 800,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 1 185,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 2 900,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 550 000,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 20 572,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 129 428,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 10 000,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 23 800,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 845,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 24 804,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 62 600,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 12 596,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 200 000,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 248 898,00 | 0,01 |
| for warrants issue | |||
| 17.11.2021 | Acquired rights | 187 029,00 | 0,01 |
| for warrants issue |
The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14
Transaction in Own Shares
2026
May 13
Transaction in Own Shares
2026
May 12
Transaction in Own Shares
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5